Condition
Major Cardiovascular Event
Total Trials
4
Recruiting
2
Active
2
Completed
0
Key Insights
Highlights
No notable highlights available yet
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
Termination Rate
0.0%
0 terminated out of 4 trials
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
0%
0 of 0 completed with results
Key Signals
Data Visualizations
Phase Distribution
2Total
Not Applicable (1)
P 1 (1)
Trial Status
Recruiting2
Not Yet Recruiting2
Clinical Trials (4)
Showing 4 of 4 trials
NCT06295679RecruitingPrimary
A Study Assessing Repatha® in Combination With Standard of Care (SOC) Compared With SOC on Major Cardiovascular Events in Chinese Participants With Atherosclerotic Cardiovascular Disease
NCT07359872Phase 1Not Yet Recruiting
Relaxin Therapy for Atrial Fibrillation
NCT06919302Not ApplicableRecruiting
The Effect of a Digital Heart Health App and Lifestyle Intervention for Heart Disease in Primary Care.
NCT06774768Not Yet Recruiting
Use of Machine-learning Algorithms, Biomarkers and Measures of Quality of Life to Personalize Medical Management of Liver and Heart Transplant Recipients
Showing all 4 trials